Carcinogenicity studies of tobacco extract in vitamin A-deficient Sprague-Dawley rats.

Abstract:

:Long-term carcinogenicity studies were carried out in male Sprague-Dawley rats maintained on vitamin A-sufficient (SLO+) and vitamin A-deficient (SLO-) diets and treated with tobacco extract (TE). Three-week-old rats received by gavage a total dose of 860 mg of TE at a daily dose of 3 mg/rat over a period of 21 months. Besides tumorigenicity, drug-metabolizing phase I and phase II enzymes in lung and liver as well as vitamin A and C levels in plasma and liver were measured at 12 and 21 months of age. The cumulative tumor incidence in TE-treated SLO- rats was significantly higher (77-100%) than that observed in TE-treated SLO+ rats (20-22%). Furthermore, SLO+ rats treated with TE showed lung and forestomach tumors, whereas TE-treated SLO- rats showed a preponderance of pituitary adenomas (87%). It was observed that TE treatment increased the activity of the hepatic and pulmonary phase I enzymes and decreased the glutathione/glutathione S-transferase detoxification system at both time points in SLO- rats. On TE treatment the vitamin A levels in the liver and plasma were significantly decreased with a concurrent increase in vitamin C levels. The data show that a vitamin A-deficient diet renders male Sprague-Dawley rats more susceptible to TE treatment than the vitamin A-sufficient diet, an effect which was associated with the augmented induction of P-450 content and activities and depletion of the glutathione/glutathione S-transferase pathway by TE.

journal_name

Cancer Res

journal_title

Cancer research

authors

Bhide SV,Ammigan N,Nair UJ,Lalitha VS

subject

Has Abstract

pub_date

1991-06-01 00:00:00

pages

3018-23

issue

11

eissn

0008-5472

issn

1538-7445

journal_volume

51

pub_type

杂志文章
  • SIRT6 promotes COX-2 expression and acts as an oncogene in skin cancer.

    abstract::SIRT6 is a SIR2 family member that regulates multiple molecular pathways involved in metabolism, genomic stability, and aging. It has been proposed previously that SIRT6 is a tumor suppressor in cancer. Here, we challenge this concept by presenting evidence that skin-specific deletion of SIRT6 in the mouse inhibits sk...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-1308

    authors: Ming M,Han W,Zhao B,Sundaresan NR,Deng CX,Gupta MP,He YY

    更新日期:2014-10-15 00:00:00

  • Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma.

    abstract::The correlation between the clinical outcome in patients with esophageal squamous cell carcinoma and coamplification of the proto-oncogenes int-2 and hst-1, which are partially homologous to angiogenesis-inducing fibroblast growth factor, was analyzed retrospectively. Coamplification of these genes was examined by slo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kitagawa Y,Ueda M,Ando N,Shinozawa Y,Shimizu N,Abe O

    更新日期:1991-03-01 00:00:00

  • Loss of tumorigenicity of Lewis lung carcinoma on the chorioallantoic membrane of the chick embryo.

    abstract::The Lewis lung carcinoma is a transplantable metastatic tumor of the C57BL mouse strain. When cells derived from this tumor are inoculated onto the chorioallantoic membrane (CAM) of 9- to 11-day-old chick embryos, large tumors are produced. Although most of these tumors contain mouse cells, they can no longer be trans...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Belin D,Ossowski L

    更新日期:1983-07-01 00:00:00

  • Selective in vivo imaging of syngeneic, spontaneous, and xenograft tumors using a novel tumor cell-specific hsp70 peptide-based probe.

    abstract::Although in vivo targeting of tumors using fluorescently labeled probes has greatly gained in importance over the last few years, most of the clinically applied reagents lack tumor cell specificity. Our novel tumor cell-penetrating peptide-based probe (TPP) recognizes an epitope of Hsp70 that is exclusively present on...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0413

    authors: Stangl S,Varga J,Freysoldt B,Trajkovic-Arsic M,Siveke JT,Greten FR,Ntziachristos V,Multhoff G

    更新日期:2014-12-01 00:00:00

  • Chromosomal analysis of sixteen human rhabdomyosarcomas.

    abstract::Chromosomal analysis of 16 rhabdomyosarcomas was done from four primary tumors and from 12 tumors after nude mouse passage. Seven tumors were alveolar; four of these had t(2;13)(q37;q14) and in two tumors it was the only structural abnormality. The other three alveolar tumors were near tetraploid with marker chromosom...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wang-Wuu S,Soukup S,Ballard E,Gotwals B,Lampkin B

    更新日期:1988-02-15 00:00:00

  • St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1.

    abstract::Commercially available St. John's wort (Hypericum perforatum) preparations and some of their main constituents (hypericin, pseudohypericin, hyperforin, rutin, and quercetin) were examined for their potential to inhibit carcinogen activation by human cytochrome P450 1A1 (CYP1A1). We used a reconstituted system consisti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Schwarz D,Kisselev P,Roots I

    更新日期:2003-11-15 00:00:00

  • Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells.

    abstract::Mounting evidence suggests a role for matrix metalloproteinase (MMP)-2 in the malignant progression of breast cancer cells. We showed previously that H-Ras, but not N-Ras, induced invasion of MCF10A human breast epithelial cells through Rac-MKK3/6-p38 pathway resulted in MMP-2 up-regulation. Activation of p38 pathway ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1461

    authors: Song H,Ki SH,Kim SG,Moon A

    更新日期:2006-11-01 00:00:00

  • Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.

    abstract::Previous electrophoretic analysis has indicated that keratins 13 and 16 (K13 and K16) are not present in normal human breast epithelium, but K16 is expressed in some ductal carcinomas (Moll et al., Cell, 31: 11-24, 1982). K16 may thus represent a marker for identifying a subset of ductal carcinomas and for distinguish...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pellegrino MB,Asch BB,Connolly JL,Asch HL

    更新日期:1988-10-15 00:00:00

  • Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers.

    abstract::Pancreatic cancer is a disease with limited therapeutic options. Resistance to chemotherapies poses a significant clinical challenge for patients with pancreatic cancer and contributes to a high rate of recurrence. Oncogenic KRAS, a critical driver of pancreatic cancer, promotes metabolic reprogramming and upregulates...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-1363

    authors: Mukhopadhyay S,Goswami D,Adiseshaiah PP,Burgan W,Yi M,Guerin TM,Kozlov SV,Nissley DV,McCormick F

    更新日期:2020-04-15 00:00:00

  • Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas.

    abstract::The combinations of amphotericin B (AmB) with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) or 2-cyclohexyl isocyanate, the carbamoylating decomposition product of CCNU, were more potent in lysing HL-60 cells than the combinations of AmB with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) or 2-chloroethyl isocyana...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Brajtburg J,Elberg S,Schechtman KB,Medoff G

    更新日期:1990-06-01 00:00:00

  • Smoking and lung cancer: an overview.

    abstract::This position paper summarizes the overwhelming evidence that tobacco smoking is the cause of 30 to 40% of deaths from cancer. The focus is on lung cancer because of the sheer magnitude of this disease in males and the likelihood of a similar epidemic in females. There are two categories of evidence that indicate smok...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Loeb LA,Ernster VL,Warner KE,Abbotts J,Laszlo J

    更新日期:1984-12-01 00:00:00

  • Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels.

    abstract::Integrin alpha(5)beta(1) is overexpressed on endothelial cells of tumor vessels and is uniformly and rapidly accessible to antibodies in the bloodstream. Here, we determined whether antibodies rapidly gain access to integrin overexpressed on the abluminal (basolateral) surface of endothelial cells through vascular lea...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2691

    authors: Magnussen A,Kasman IM,Norberg S,Baluk P,Murray R,McDonald DM

    更新日期:2005-04-01 00:00:00

  • Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein.

    abstract::Fumitremorgin C (FTC) is a potent and specific chemosensitizing agent in cell lines selected for resistance to mitoxantrone that do not overexpress P-glycoprotein or multidrug resistance protein. The gene encoding a novel transporter, the breast cancer resistance protein (BCRP), was recently found to be overexpressed ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rabindran SK,Ross DD,Doyle LA,Yang W,Greenberger LM

    更新日期:2000-01-01 00:00:00

  • Synergistic effect of the v-myc oncogene with H-ras on radioresistance.

    abstract::Resistance of tumors to irradiation or chemotherapeutic agents is thought to be one of the reasons why patients who present with early malignancies may not be cured. Much is now known about the molecular mechanisms that underlie drug resistance, but until recently little was known about genetic contributions to radiat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: McKenna WG,Weiss MC,Endlich B,Ling CC,Bakanauskas VJ,Kelsten ML,Muschel RJ

    更新日期:1990-01-01 00:00:00

  • Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells.

    abstract::Whereas transplantable tumors can be readily cured with immunotherapeutic approaches, similar therapies in cancer patients have been less effective. This difference may be explained by an immunosuppression resulting from the presence of a slowly growing primary tumor in the patient, whereas the immune system in a mous...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Horiguchi S,Petersson M,Nakazawa T,Kanda M,Zea AH,Ochoa AC,Kiessling R

    更新日期:1999-06-15 00:00:00

  • Identification of fractalkine, a CX3C-type chemokine, as a direct target of p53.

    abstract::Fractalkine is a CX3C-type chemokine that induces chemotaxis of monocytes and cytotoxic T cells. Using the differential display method for examining gene expression in p53-defective cells transfected by adenovirus containing wild-type p53, we observed that fractalkine was induced by ectopic expression of p53. An elect...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shiraishi K,Fukuda S,Mori T,Matsuda K,Yamaguchi T,Tanikawa C,Ogawa M,Nakamura Y,Arakawa H

    更新日期:2000-07-15 00:00:00

  • Inhibition of local and metastatic hepatoma growth and prolongation of survival after induction of hypothyroidism.

    abstract::The local growth rate of Morris Hepatoma 44 (generation time, 6 months) was inhibited by 66 to 87%, and host survival was prolonged by 36 to 78% after the induction of hypothyroidism within 2 weeks of tumor implantation by propylthiouracil (0.1% in Purina chow), 131I(1 mCi/100 g body weight i.p.), or surgical thyroide...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mishkin SY,Pollack R,Yalovsky MA,Morris HP,Mishkin S

    更新日期:1981-08-01 00:00:00

  • LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer.

    abstract::Epithelial-mesenchymal transition (EMT), a switch of polarized epithelial cells to a migratory, fibroblastoid phenotype, is considered a key process driving tumor cell invasiveness and metastasis. Using breast cancer cell lines as a model system, we sought to discover gene expression signatures of EMT with clinical an...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3141

    authors: Choi YL,Bocanegra M,Kwon MJ,Shin YK,Nam SJ,Yang JH,Kao J,Godwin AK,Pollack JR

    更新日期:2010-03-15 00:00:00

  • Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells.

    abstract::Berberine, a natural product derived from a plant used in Chinese herbal medicine, is reported to exhibit anticancer effects; however, its mechanism of action is not clearly defined. Herein, we demonstrate that berberine induces apoptosis in acute lymphoblastic leukemia (ALL) cells by downregulating the MDM2 oncoprote...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-1546

    authors: Zhang X,Gu L,Li J,Shah N,He J,Yang L,Hu Q,Zhou M

    更新日期:2010-12-01 00:00:00

  • Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity.

    abstract::Small-molecule inhibitors of PARP1/2, such as olaparib, have been proposed to serve as a synthetic lethal therapy for cancers that harbor BRCA1 or BRCA2 mutations. Indeed, in clinical trials, PARP1/2 inhibitors elicit sustained antitumor responses in patients with germline BRCA gene mutations. In hypothesizing that ad...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-2541

    authors: Bajrami I,Frankum JR,Konde A,Miller RE,Rehman FL,Brough R,Campbell J,Sims D,Rafiq R,Hooper S,Chen L,Kozarewa I,Assiotis I,Fenwick K,Natrajan R,Lord CJ,Ashworth A

    更新日期:2014-01-01 00:00:00

  • Suppression of intracranial human glioma growth after intramuscular administration of an adeno-associated viral vector expressing angiostatin.

    abstract::Despite various therapeutic interventions, glioblastoma multiforme (GBM) is one of the most highly vascularized neoplasms in humans with poor prognosis. In this study, we show that a single i.m. injection of an adeno-associated viral (AAV) vector expressing angiostatin, a potent angiogenic inhibitor, effectively suppr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ma HI,Guo P,Li J,Lin SZ,Chiang YH,Xiao X,Cheng SY

    更新日期:2002-02-01 00:00:00

  • Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis.

    abstract::Amphoterin has been suggested to regulate invasive process extension and cell migration in tumor cells and embryonic neurons through binding to receptor for advanced glycation end products (RAGE), a multiligand transmembrane receptor belonging to the immunoglobulin superfamily. In this study, we identify a COOH-termin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Huttunen HJ,Fages C,Kuja-Panula J,Ridley AJ,Rauvala H

    更新日期:2002-08-15 00:00:00

  • Assessment of protein kinase C isozymes by enzyme immunoassay and overexpression of type II in thyroid adenocarcinoma.

    abstract::A two site enzyme immunoassay which quantitatively identifies types I, II, and III of protein kinase C isozymes has been designed. The soluble protein kinase C isozymes were selectively immobilized by type-specific monoclonal antibodies, MC-1a, -2a, and -3a (H. Hidaka et al., J Biol. Chem., 263: 4523-4526, 1988) which...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hagiwara M,Hachiya T,Watanabe M,Usuda N,Iida F,Tamai K,Hidaka H

    更新日期:1990-09-01 00:00:00

  • The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors.

    abstract::Thymidine phosphorylase (TP) is an enzyme involved in the reversible conversion of thymidine to thymine and is identical to an angiogenic factor, platelet-derived endothelial cell growth factor. TP is expressed at higher levels in a wide variety of solid tumors than in the adjacent nonneoplastic tissues. Patients with...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Matsushita S,Nitanda T,Furukawa T,Sumizawa T,Tani A,Nishimoto K,Akiba S,Miyadera K,Fukushima M,Yamada Y,Yoshida H,Kanzaki T,Akiyama S

    更新日期:1999-04-15 00:00:00

  • Therapy of advanced established murine breast cancer with a recombinant adenoviral ErbB-2/neu vaccine.

    abstract::ErbB-2 (HER-2/neu) is a transforming oncogene expressed by a substantial fraction of breast cancers, and monoclonal antibody therapy directed toward this antigen is an established treatment modality. However, not all tumors respond, and with a monoclonal antibody directed to a single epitope, there is always the risk ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5688

    authors: Park JM,Terabe M,Steel JC,Forni G,Sakai Y,Morris JC,Berzofsky JA

    更新日期:2008-03-15 00:00:00

  • Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer.

    abstract::Pentraxin-3 (PTX3) is a member of the pentraxin family of innate immune regulators, which includes C-reactive protein (CRP). PTX3 has been implicated in angiogenesis, proliferation, and immune escape in cancer. In the present study, we evaluated PTX3 tissue expression and serum concentration as a biomarker to discrimi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0369

    authors: Stallone G,Cormio L,Netti GS,Infante B,Selvaggio O,Fino GD,Ranieri E,Bruno F,Prattichizzo C,Sanguedolce F,Tortorella S,Bufo P,Grandaliano G,Carrieri G

    更新日期:2014-08-15 00:00:00

  • Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.

    abstract::Cell-mediated cytotoxicity against syngeneic MC104 fibrosarcoma cells was detected in C57BL/6N mice 7 days after tumor inoculation in the hind foot. This cytotoxicity was undetectable by Day 14 in the Winn test using spleen and draining popliteal lymph node (DPLN) cells. Similar results were obtained with the 51Cr rel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kawase I,Uemiya M,Yoshimoto T,Ogura T,Hirao F,Yamamura Y

    更新日期:1981-02-01 00:00:00

  • Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers.

    abstract::4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronides (sum of which is denoted as total NNAL) are metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). NNK and NNAL can induce lung cancer in laboratory animals but human data are limited. The association between prediagnostic levels o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4330

    authors: Yuan JM,Koh WP,Murphy SE,Fan Y,Wang R,Carmella SG,Han S,Wickham K,Gao YT,Yu MC,Hecht SS

    更新日期:2009-04-01 00:00:00

  • α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration.

    abstract::Metastatic cases of breast cancer pose the primary challenge in clinical management of this disease, demanding the identification of effective therapeutic strategies that remain wanting. In this study, we report that elevated levels of α-tubulin acetylation are a sufficient cause of metastatic potential in breast canc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-3563

    authors: Boggs AE,Vitolo MI,Whipple RA,Charpentier MS,Goloubeva OG,Ioffe OB,Tuttle KC,Slovic J,Lu Y,Mills GB,Martin SS

    更新日期:2015-01-01 00:00:00

  • NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia.

    abstract::A novel chromosomal translocation, t(2;11)(q31;p15), was identified in a patient with therapy-related acute myelogenous leukemia (t-AML). Fluorescence in situ hybridization experiments mapped the breakpoint near NUP98; Southern blot analysis demonstrated that the nucleoporin gene NUP98 was disrupted by this translocat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Raza-Egilmez SZ,Jani-Sait SN,Grossi M,Higgins MJ,Shows TB,Aplan PD

    更新日期:1998-10-01 00:00:00